Glatiramer is primarily used to treat specific forms of multiple sclerosis (MS) in adults.
Types of MS Treated with Glatiramer
Glatiramer acetate is a medication specifically indicated for managing relapsing forms of multiple sclerosis. These include:
- Clinically Isolated Syndrome (CIS): This is often the first episode of neurological symptoms that could indicate MS.
- Relapsing-Remitting MS (RRMS): The most common form of MS, characterized by clear relapses (flare-ups) followed by periods of remission.
- Active Secondary Progressive MS (SPMS): A stage of MS where the disease transitions from relapsing-remitting to a more progressive form with less distinct relapses and more constant worsening of symptoms.
Key Points about Glatiramer Use
- Glatiramer works by modifying the immune system's activity to reduce inflammation and damage to the myelin sheath, which protects nerve fibers.
- It is typically administered via subcutaneous (under the skin) injection.
- It is important to note that glatiramer treats the disease course rather than providing symptomatic relief during an acute MS flare.
How Glatiramer Works
Glatiramer is not a cure for MS, but it helps to:
- Reduce the frequency of relapses.
- Slow the progression of disability.
- Decrease the number of brain lesions.
Reference
The information in this document is based on the following reference:
- Glatiramer is indicated to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. (28-Feb-2024)
